All updated as on -
The market for particle therapy is estimated to be worth USD 2.40 million in 2030 and is anticipated to grow at a 10.3% CAGR from 2023 to 2030.
One of the world's most cutting-edge forms of external beam radiation therapy for oncology is particle therapy. Compared to conventional photon therapy, this technique preserves more radiation-free healthy tissue. Due to the improved physical intrinsic properties of these particles, the intake dose was reduced to around half of what a clinically suitable aim would be. The market is expected to expand due to factors such the rising incidence of cancer, the low risk of treatment-related illnesses, the possibility of radiation dosage retreatment, and the expanding number of particle therapy facilities globally. Additionally, market expansion is being fueled by higher R&D spending and aggressive strategies adopted by top businesses, like the release of new products. The benefits of particle treatment and the rising incidence of cancer worldwide are driving market growth. The number of people affected by various cancers has been found to be a key driving factor for this market. One of the most prevalent illnesses today that can lead to death is cancer. About 70% of deaths in low- and middle-income countries are caused by cancer. Particle therapies are used to treat cancer, thus it is anticipated that their rising popularity will be a key factor in the market's growth.
The major factor accelerating the market growth is the rising incidence of cancer across the globe. Other important drivers of the particle therapy market include the rising use of particle therapy in clinical trials, the rising number of particle therapy centers globally, the rising incidence of cancer, the rising investment in cancer research, and the rising incidence of particle therapy centers and clinical trials. Additionally, rising research and development activities in the healthcare industry, rising emerging markets with an increasing geriatric population base, and rising technological advancements and modernization in healthcare equipment will further create new opportunities for the particle therapy market in the anticipated period of 2021–2028.
However, among other things, increasing unfavorable reimbursement policies, increasing affordability and accessibility of treatments, and limited insurance coverage for particle therapy are the main factors which will restrain market growth and pose additional challenges to the expansion of the particle therapy market during the forecast period mentioned above.
The COVID-19 pandemic may have slowed the development of paradigm-shifting advances in particles that could enhance the quality of life for present and future generations. However, businesses in the particle therapy sector are adjusting to the new norm by maintaining care services for cancer patients who are at high risk and who are also vulnerable. Cancer treatment centers are putting strict safety standards in place as well as modifications for the patients and employees. Cancer treatment facilities are putting in place a number of safeguards to guarantee that safety measures are followed, including regular checks of all staff members, patients, and visitors. A further impact of the pandemic on the global healthcare sector would undoubtedly be the development of telemedicine and remote patient monitoring.
Particle therapy is increasingly used in clinical trials, there are more particle therapy facilities worldwide, more cases of cancer, more money is being invested in cancer research, and there are more particle therapy facilities and clinical trials in North America, which is why this region dominates the market. Due to rising per capita income, improved healthcare infrastructure, and more government backing in nations like China, Japan, and India, Europe and Asia-Pacific are the regions likely to experience growth in the particle treatment market.
The nation-specific market affecting variables and domestic market regulation changes that have an impact on the market's present and future trends are also provided in the particle therapy market report's country section. Some of the key data points used to estimate the market situation for specific nations are consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, and upstream and downstream value chain analysis. When giving prediction analysis of the country data, it also takes into account the presence and accessibility of international brands, the difficulties they encounter owing to strong or weak competition from local and domestic brands, the influence of domestic tariffs, and trade routes.
Report Coverage
Global Particle Therapy research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Particle Therapy report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Particle Therapy competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Particle Therapy market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Particle Therapy market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Particle Therapy market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Advanced Oncotherapy, IBA Worldwide, Accuray Incorporated, Brainlab, Elekta AB, Panacea, Shinva Medical Instrument Co. Ltd, xstrahl, Danfysik A/S, Hitachi Ltd., Mevion Medical Systems, Optivus Proton Therapy Inc., ProTom International, Provision Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., SAH Global LLC, Mitsubishi Electric Corporation, Koninklijke Philips N.V. and PTW Freiburg GmbH. among other
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Particle Therapy market based on the below-mentioned segments:
Global Particle Therapy Market, By Type
Proton Therapy
Heavy Ion Therapy
Global Particle Therapy market, By Application
Treatment Applications
Research Applications
Global Particle Therapy Market, By Cancer Type
Prostate Cancer
Lung Cancer
Pediatric Cancer
Head and Neck Cancer
Breast Cancer
Others
Global Particle Therapy market, Regional Analysis
One of the world's most cutting-edge forms of external beam radiation therapy for oncology is particle therapy. Compared to conventional photon therapy, this technique preserves more radiation-free healthy tissue. Due to the improved physical intrinsic properties of these particles, the intake dose was reduced to around half of what a clinically suitable aim would be. The market is expected to expand due to factors such the rising incidence of cancer, the low risk of treatment-related illnesses, the possibility of radiation dosage retreatment, and the expanding number of particle therapy facilities globally. Additionally, market expansion is being fueled by higher R&D spending and aggressive strategies adopted by top businesses, like the release of new products. The benefits of particle treatment and the rising incidence of cancer worldwide are driving market growth. The number of people affected by various cancers has been found to be a key driving factor for this market. One of the most prevalent illnesses today that can lead to death is cancer. About 70% of deaths in low- and middle-income countries are caused by cancer. Particle therapies are used to treat cancer, thus it is anticipated that their rising popularity will be a key factor in the market's growth.
The major factor accelerating the market growth is the rising incidence of cancer across the globe. Other important drivers of the particle therapy market include the rising use of particle therapy in clinical trials, the rising number of particle therapy centers globally, the rising incidence of cancer, the rising investment in cancer research, and the rising incidence of particle therapy centers and clinical trials. Additionally, rising research and development activities in the healthcare industry, rising emerging markets with an increasing geriatric population base, and rising technological advancements and modernization in healthcare equipment will further create new opportunities for the particle therapy market in the anticipated period of 2021–2028.
However, among other things, increasing unfavorable reimbursement policies, increasing affordability and accessibility of treatments, and limited insurance coverage for particle therapy are the main factors which will restrain market growth and pose additional challenges to the expansion of the particle therapy market during the forecast period mentioned above.
The COVID-19 pandemic may have slowed the development of paradigm-shifting advances in particles that could enhance the quality of life for present and future generations. However, businesses in the particle therapy sector are adjusting to the new norm by maintaining care services for cancer patients who are at high risk and who are also vulnerable. Cancer treatment centers are putting strict safety standards in place as well as modifications for the patients and employees. Cancer treatment facilities are putting in place a number of safeguards to guarantee that safety measures are followed, including regular checks of all staff members, patients, and visitors. A further impact of the pandemic on the global healthcare sector would undoubtedly be the development of telemedicine and remote patient monitoring.
Particle therapy is increasingly used in clinical trials, there are more particle therapy facilities worldwide, more cases of cancer, more money is being invested in cancer research, and there are more particle therapy facilities and clinical trials in North America, which is why this region dominates the market. Due to rising per capita income, improved healthcare infrastructure, and more government backing in nations like China, Japan, and India, Europe and Asia-Pacific are the regions likely to experience growth in the particle treatment market.
The nation-specific market affecting variables and domestic market regulation changes that have an impact on the market's present and future trends are also provided in the particle therapy market report's country section. Some of the key data points used to estimate the market situation for specific nations are consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, and upstream and downstream value chain analysis. When giving prediction analysis of the country data, it also takes into account the presence and accessibility of international brands, the difficulties they encounter owing to strong or weak competition from local and domestic brands, the influence of domestic tariffs, and trade routes.
Report Coverage
Global Particle Therapy research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Particle Therapy report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Particle Therapy competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Particle Therapy market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Advanced Oncotherapy, IBA Worldwide, Accuray Incorporated, Brainlab, Elekta AB, Panacea, Shinva Medical Instrument Co. Ltd, xstrahl, Danfysik A/S, Hitachi Ltd., Mevion Medical Systems, Optivus Proton Therapy Inc., ProTom International, Provision Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., SAH Global LLC, Mitsubishi Electric Corporation, Koninklijke Philips N.V. and PTW Freiburg GmbH. among other |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Particle Therapy Market from 2021 to 2030.
- Market Forecast for Particle Therapy Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Particle Therapy competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Particle Therapy
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Particle Therapy market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Particle Therapy market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Advanced Oncotherapy, IBA Worldwide, Accuray Incorporated, Brainlab, Elekta AB, Panacea, Shinva Medical Instrument Co. Ltd, xstrahl, Danfysik A/S, Hitachi Ltd., Mevion Medical Systems, Optivus Proton Therapy Inc., ProTom International, Provision Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., SAH Global LLC, Mitsubishi Electric Corporation, Koninklijke Philips N.V. and PTW Freiburg GmbH. among other
Primary Target Market
- Market Players of Particle Therapy
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Particle Therapy market based on the below-mentioned segments:
Global Particle Therapy Market, By Type
Proton Therapy
Heavy Ion Therapy
Global Particle Therapy market, By Application
Treatment Applications
Research Applications
Global Particle Therapy Market, By Cancer Type
Prostate Cancer
Lung Cancer
Pediatric Cancer
Head and Neck Cancer
Breast Cancer
Others
Global Particle Therapy market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive particle therapy market market research and competitor analysis for your business to help you develop more profound insights into the particle therapy market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the particle therapy market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.